Renewed Confidence In Data, Launches Drive J.P. Morgan Stocks
This article was originally published in The Pink Sheet Daily
Executive Summary
Several big and mid-cap biopharmas successfully maneuvered at the seminal conference for the industry, garnering sizeable stock moves as a reward. But it’s not clear yet if the market upswing signals continued sector momentum or a brief peak.